Fairmount Funds Management LLC invests in Series, Series B, and post-IPO equity rounds. Organization, location and related investors we track.
Fairmount Funds Management LLC invests in Series A, Series B, and post-IPO equity rounds of biotechnology and life science companies developing differentiated therapeutics, with a recent tracked check size of $150 million for Korsana Biosciences' Series A. The firm's distinctive thesis centers on backing emerging life sciences organizations that combine robust research pipelines with experienced management teams to deliver innovative treatments. Notable portfolio companies include Cogent Biosciences, Zenas BioPharma (which saw a Fairmount-supported IPO exit), Damora Therapeutics, and Interius BioTherapeutics.
Every field above is read from the StartupFundraising firm directory — disclosed location, recorded investments and stated focus — and re-checked as filings arrive. Founders pair it with investors in West Conshohocken when building a target list.
Investors like Fairmount Funds Management LLC · Full investor directory · Investor access · Company funding database